رجوع
نطاق اليوم
KWD 67.59
KWD 71.55
نطاق 52 أسبوعًا
KWD 55.17
KWD 170.87
حجم التداول
385,767
متوسط 50 يوم / 200 يوم
KWD 91.52
/
KWD 111.11
الإغلاق السابق
KWD 72.14
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -95.7 | 0.3 |
| P/B | 6.5 | 2.9 |
| ROE % | -7.6 | 3.7 |
| Net Margin % | -4.9 | 3.8 |
| Rev Growth 5Y % | 19.1 | 10.0 |
| D/E | 0.5 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 157.500
+129.4%
Low: KWD 130.000
High: KWD 170.000
مكرر الربحية المستقبلي
90.7
ربحية السهم المستقبلية
KWD 0.795
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
550 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 8.760
KWD 8.532 – KWD 8.961
|
1.4 B | 1 |
| FY2029 |
KWD 5.263
KWD 5.127 – KWD 5.384
|
1 B | 1 |
| FY2028 |
KWD 3.048
KWD 0.656 – KWD 5.440
|
840 M | 2 |
النقاط الرئيسية
Revenue grew 19.14% annually over 5 years — strong growth
Debt/Equity of 0.49 — conservative balance sheet
Generating 14.26M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 20.83%
Capital efficient — spends only 4.45% of revenue on capex
النمو
Revenue Growth (5Y)
19.14%
Revenue (1Y)39.97%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-7.60%
ROIC-1.92%
Net Margin-4.92%
Op. Margin-2.76%
الأمان
Debt / Equity
0.49
Current Ratio2.46
Interest Coverage-4.65
التقييم
P/E Ratio
-95.68
P/B Ratio6.53
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 39.97% | Revenue Growth (3Y) | 45.28% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 19.14% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 427.54M | Net Income (TTM) | -21.02M |
| ROE | -7.60% | ROA | -3.69% |
| Gross Margin | 69.74% | Operating Margin | -2.76% |
| Net Margin | -4.92% | Free Cash Flow (TTM) | 14.26M |
| ROIC | -1.92% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.49 | Current Ratio | 2.46 |
| Interest Coverage | -4.65 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -95.68 | P/B Ratio | 6.53 |
| P/S Ratio | 4.70 | PEG Ratio | 2.67 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.01B | Enterprise Value | 2.06B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 427.54M | 305.45M | 202.57M | 234.69M | 212.20M |
| Net Income | -21.02M | -52.29M | -175.77M | -548.98M | -245.39M |
| EPS (Diluted) | -0.73 | -1.94 | -7.23 | -53.63 | -74.93 |
| Gross Profit | 298.17M | 194.40M | 90.01M | -26.75M | -16.60M |
| Operating Income | -11.80M | -23.21M | -180.60M | -667.65M | -446.15M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 570.19M | 419.38M | 418.76M | 545.26M | 554.09M |
| Total Liabilities | 262.01M | 174.13M | 190.74M | 291.56M | 165.99M |
| Shareholders' Equity | 308.18M | 245.25M | 228.02M | 253.71M | 388.10M |
| Total Debt | 151.95M | 116.17M | 119.77M | 77.13M | 32.85M |
| Cash & Equivalents | 105.00M | 85.21M | 99.68M | 137.40M | 400.57M |
| Current Assets | 268.29M | 197.97M | 182.34M | 212.62M | 483.54M |
| Current Liabilities | 108.91M | 54.82M | 58.82M | 144.30M | 101.28M |